CellProthera has acquired full rights to the transendocardial catheter originally [...]
NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]
CellProthera has acquired full rights to the transendocardial catheter originally [...]
NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]